AMRE 26.50 Amreit Inc $AMRE Hit a 52 week high of 26.60

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
AMRE 26.50 Amreit Inc $AMRE Hit a 52 week high of 26.60 Currently at 26.50 -0.19 -0.71% With a day low of 26.50 and a total volume of 3,563.

AMRE Amreit Inc Recent Headline News

AMREIT, INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of AmREIT, Inc. (AMRE) Over the Proposed Sale of the Company to Edens Investment Trust
PR Newswire - Thu Nov 06, 3:42PM CST
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of AmREIT, Inc. ("AmREIT" or the "Company" (NYSE:AMRE) for potential breaches of fiduciary duties in connection with the sale of the Company to Edens Investment Trust ("Edens" for approximately $763 million. The Company's stockholders will receive $26.55 for each share of AmREIT common stock they own.
AMRE: 26.50 (-0.19)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation of the Board of Directors of AmREIT, Inc. in Connection With the Fairness of the Sale of the Company to Edens Investment Trust
Business Wire - Thu Nov 06, 2:48PM CST
Levi & Korsinsky is investigating the Board of Directors of AmREIT, Inc. ("AmREIT" or "the Company" (NYSE:AMRE) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Edens Investment Trust.
AMRE: 26.50 (-0.19)

Robbins Arroyo LLP: Acquisition of AmREIT Inc. (AMRE) by Edens Investment Trust May Not Be in Shareholders' Best Interests
PR Newswire - Wed Nov 05, 7:10PM CST
Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of AmREIT Inc. (NYSE: AMRE) by Edens Investment Trust, a private company. On October 31, 2014, AmREIT announced the signing of a definitive merger agreement pursuant to which Edens will acquire all the outstanding shares of AmREIT for $26.55 per share in cash.
AMRE: 26.50 (-0.19)

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of AmREIT, Inc. in Connection with the Sale of the Company
Business Wire - Wed Nov 05, 5:35PM CST
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of AmREIT, Inc. ("AmREIT" or the "Company" (NYSE: AMRE) relating to the proposed acquisition by Edens Investment Trust ("Edens".
AMRE: 26.50 (-0.19)

AMREIT, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
PR Newswire - Wed Nov 05, 12:59PM CST
Rigrodsky & Long, P.A.:
AMRE: 26.50 (-0.19)

Lifshitz & Miller Law Firm Announces Investigation of AmREIT, Inc., Digital River, Inc., Greater Sacramento Bancorp., Hampden Bancorp, Inc., Integrity Bancshares, Inc., Retrophin, Inc. and Sapient Corp.
PR Newswire - Wed Nov 05, 11:33AM CST
AmREIT, Inc.
HBNK: 19.78 (-0.13), DRIV: 24.60 (-0.17), AMRE: 26.50 (-0.19), SAPE: 24.66 (+0.01), RTRX: 10.75 (+0.01)

AmREIT Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Edens Investment Trust
Business Wire - Tue Nov 04, 10:56AM CST
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of AmREIT, Inc. ("AmREIT" (NYSE: AMRE) concerning the acquisition by Edens Investment Trust. Under the terms of the agreement AmREIT shareholders will only receive $26.55 in cash per AmREIT share owned.
AMRE: 26.50 (-0.19)

EQUITY ALERT: The Rosen Law Firm Announces Investigation of AmREIT, Inc. Concerning its Proposed Sale to Edens Investment Trust - AMRE
Business Wire - Tue Nov 04, 10:55AM CST
The Rosen Law Firm, P.A. announces that it is investigating the Board of Directors of AmREIT, Inc. (NYSE: AMRE) for possible breaches of fiduciary duty and other violations of law by failing to adequately shop AmREIT to maximize shareholder value before agreeing to be acquired by Edens Investment Trust.
AMRE: 26.50 (-0.19)

AMRE INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation into the Board of Directors of AmREIT, Inc. Regarding the Fairness of the Sale of the Company to Edens Investment Trust -- AMRE
PR Newswire - Tue Nov 04, 10:40AM CST
Levi & Korsinsky is investigating the Board of Directors of AmREIT, Inc. ("AmREIT" or "the Company" (NYSE: AMRE) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Edens Investment Trust.
AMRE: 26.50 (-0.19)

AmREIT Inc declares $0.20 dividend
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 7:39AM CST

AMRE: 26.50 (-0.19)

AmREIT Reports Third Quarter Results and Declares December 2014 Dividend
Business Wire - Tue Nov 04, 7:31AM CST
AmREIT, Inc. (NYSE:AMRE) ("AmREIT" or the "Company" today announced financial results for the third quarter ended September 30, 2014 and declared dividends for the fourth quarter ending December 31, 2014.
AMRE: 26.50 (-0.19)

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of AmREIT, Inc. in Connection with the Sale of the Company -AMRE
PR Newswire - Mon Nov 03, 8:35PM CST
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of AmREIT, Inc.. ("AmREIT" or the "Company" (NYSE -AMRE-News) relating to the proposed acquisition by Edens Investment Trust. ("Edens".
AMRE: 26.50 (-0.19)

AmREIT INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AmREIT, Inc.
PR Newswire - Mon Nov 03, 7:41PM CST
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF" are investigating the proposed sale of AmREIT, Inc. ("AmREIT" or the "Company" (NYSE: AMRE) to Edens Investment Trust. Under the terms of the proposed transaction, shareholders of AmREIT will receive only $26.55 in cash for each share of AmREIT common stock that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
AMRE: 26.50 (-0.19)

AmREIT signs definitive acquisition agreement with EDENS for USD763m total cash
M2 - Mon Nov 03, 7:27AM CST
AmREIT Inc (NYSE:AMRE), a real estate investment trust, revealed on Saturday that it has signed a definitive agreement with Edens Investment Trust (EDENS), under which all outstanding shares of AMREIT common stock will be bought for USD26.55 per share in an all-cash transaction by EDENS, with a total enterprise value of about USD763m.
AMRE: 26.50 (-0.19), REG: 61.78 (-0.32)

AmREIT to Be Acquired by EDENS for $26.55 Per Share
Business Wire - Fri Oct 31, 10:29PM CDT
AmREIT, Inc. (NYSE:AMRE) today announced that it has entered into a definitive agreement with Edens Investment Trust ("EDENS" under which EDENS will acquire all outstanding shares of common stock of AmREIT for $26.55 per share in an all-cash transaction with a total enterprise value of approximately $763 million.
AMRE: 26.50 (-0.19), REG: 61.78 (-0.32)

AmREIT Expands Its Portfolio of Irreplaceable Corners in Atlanta with the Acquisition of Tuxedo Festival Shopping Center
Business Wire - Mon Aug 25, 3:15PM CDT
AmREIT, Inc., announced today that it has completed the acquisition of Tuxedo Festival Shopping Center, a 54,643 square foot shopping center located on 3.96 acres in the Buckhead submarket of Atlanta, Georgia.
AMRE: 26.50 (-0.19)

Regency Touches New 52-Week High on Solid Second Quarter Performance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 10:20AM CDT
Shares of Regency Centers (REG) reached a 52-week high of $57.14 during the trading session on Friday, Aug 15, after gaining momentum on solid second-quarter 2014 results.
JLL: 139.83 (-0.19), AMRE: 26.50 (-0.19), CUZ: 12.87 (-0.13), REG: 61.78 (-0.32)

Regency Q2 FFO Beats on Higher Revenues, Raises Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 07, 9:40AM CDT
Higher revenue growth kept Regency Centers Corporation's (REG) winning streak going, with a positive earnings surprise of around 6.0% in second-quarter 2014.
GGP: 25.60 (-0.16), AMRE: 26.50 (-0.19), REG: 61.78 (-0.32), MCO: 99.24 (-0.08)

AmREIT Reports Second Quarter Results and Declares September 2014 Dividend
Business Wire - Tue Jul 29, 3:07PM CDT
AmREIT, Inc. (NYSE: AMRE) ("AmREIT" or the "Company" today announced financial results for the second quarter ended June 30, 2014 and declared dividends for the third quarter ending September 30, 2014.
AMRE: 26.50 (-0.19)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ambient AI Shows Promise for Boosting Cancer Care Efficiency

Updated Category News Views 193

Study Points to Ambient AI's Promise in Oncology Some days, the world of cancer care is a real beast to tackle. But today, we've got a glimpse into how technology, and specifically ambient AI, might just help slay some of the burdens that these healthcare warriors face daily. The Florida Cancer Specialists & Research Institute (FCS) joined hands to dive into how this tech...

Continue Reading
Independents Finally Center Stage on Election Night

Updated Category News Views 67

Unprecedented Spotlight on Independent Voters The political landscape is in for a shake-up, folks. Come November 3rd, we're witnessing something that hasn't been done before—an entire Election Night dedicated exclusively to independent voters. It’s high time these folks got the spotlight, considering a whopping 45% of U.S. adults have shunned the extremist seesaw of...

Continue Reading
Fair Play in Focus: SYNA, CSR, VCTR, EFSI Deals Scrutinized

Updated Category News Views 166

The Corporate Buzz: Deals Under the Microscope Riding the rollercoaster of mergers and acquisitions ain't new in the stock market realm. But when the stakes seem one-sided, alarms start ringing. Halper Sadeh LLC, a firm that cuts its teeth on this kind of corporate sleuthing, is all hands on deck probing a slew of big deals involving Synaptics (NASDAQ:SYNA), Centerspace...

Continue Reading
New Drug Revolutionizes Endometrial Cancer Treatment

Updated Category News Views 87

A New Dawn for Endometrial Cancer Treatment Alright, every once in a while, something shakes up the world of oncology. And that's exactly what's happening with sacituzumab tirumotecan, or sac-TMT if you want to save your breath. This new drug is stepping up as a future star in the fight against endometrial cancer, according to an eye-popping international study led by NYU...

Continue Reading
Cleveland Youth Team Uses Global Catch for Fundraising

Updated Category News Views 84

Turning a Simple Game into a Global Campaign Sometimes, you just need a fresh angle to hit a home run, and that's what Thunder Baseball is counting on. The Cleveland-based 501(c)(3) youth baseball organization is ditching the old fundraising playbook. No more cookie-cutter raffles or bake sales. Instead, they’re launching a campaign that taps into the universal joy of...

Continue Reading
Coastal Financial Faces Lawsuit Amid Massive Stock Hit

Updated Category News Views 125

Coastal Financial Corporation's (NASDAQ:CCB) recent nosedive is more distressing than a rollercoaster ride. After a 43.52% stock drop, investors are furious, to say the least. What tipped the scales? Coastal's financial revelations painted a bleak picture, but that’s just scratching the surface of a mess that has folks heading for legal battles. Behind the Numbers: The...

Continue Reading
Keeper Security Shines in Gartner's 2026 PAM Report

Updated Category News Views 111

Recognition That Stands Out When you're in the security game, being flagged in the Gartner® Magic Quadrant™ is like getting the thumbs-up from the industry's toughest critic. Keeper Security just snagged that recognition for the second year straight, and what's putting feathers in their cap? A completeness of vision and the chops to execute—no small feat in the wild...

Continue Reading
Google Faces Investor Lawsuit Over AI Model Delays

Updated Category News Views 0

Alphabet's in hot water, folks—a class action lawsuit's been slapped on the giant for allegedly pulling the wool over investors' eyes about its highly touted Gemini 3.5 Pro AI model. This ain't just a slap-on-the-wrist scenario; we're talking about allegations of securities fraud that's got Alphabet's shareholders clutching their stock certificates and wondering how it...

Continue Reading
Bank of America Faces Securities Fraud Suit Amidst Stock Dip

Updated Category News Views 0

Bank of America in Hot Water Over Compliance Issues No one likes waking up to a legal mess, especially shareholders. Bank of America finds itself knee-deep in a class action lawsuit. What kicked off this chain reaction of legal turmoil? Allegations that the bank downplayed their dirty laundry concerning the Bank Secrecy Act and anti-money laundering compliance failures....

Continue Reading
Teamsters Secure Strong Contract for CA Waste Workers

Updated Category News Views 99

Teamsters Flex Muscles in So-Cal Sanitation Sector So here's one for the books: 700 Waste Management workers represented by Teamsters Local 396 just locked down a fresh collective bargaining agreement in Los Angeles and Orange counties. And let me tell you, this isn’t just another contract—it's a testament to what solidarity can wring out of a massive corporation. The...

Continue Reading

Top 5 Most Recently Viewed Articles

Tourmo Secures Growth Funds for Innovative Fleet Solutions

Updated Category News Views 341

Tourmo Receives Growth Investment to Enhance Fleet Operations Tourmo has successfully secured a substantial growth debt transaction from Decathlon Capital Partners to fuel its expansion efforts. This innovative financing structure is set to enhance the capabilities of Tourmo, a leader in AI-powered Fleet Operations intelligence solutions. Impact of the Funding on Tourmo...

Continue Reading
Buildforce's $10M Boost: Powering Next Growth Phase

Updated Category News Views 38

Ah, the scent of fresh investment is wafting in, folks. Buildforce, the mover and shaker in the tech-enabled electrician staffing scene, just snagged a cool $10 million in Series A financing. Now, if you're wondering why a staffing company is worth all the buzz, let's dig into the nitty-gritty. The Money Behind the Madness Leading the charge in this funding bonanza is...

Continue Reading
Navigating the Global Debt Crisis: Opportunities and Risks

Updated Category News Views 127

Understanding the Surge in Global Debt We find ourselves at a pivotal moment in the global economy, as debt continues to soar to unprecedented heights. Recent findings reveal that the total world debt has surged to approximately US$ 346 trillion. This staggering figure represents about 310% of the global GDP, highlighting our reliance on debt financing to sustain economic...

Continue Reading
Replica Cyber Innovates Platform for Enhanced Security and Growth

Updated Category News Views 151

Introduction to Replica Cyber's Evolved Platform Replica Cyber stands as a pioneering force in Zero-Trust Isolated Environments, committed to enhancing the security and operational functionality of businesses and government entities. Their latest announcement unveils a transformative evolution of the Replica platform, designed to improve how organizations carry out...

Continue Reading
Telomir Pharmaceuticals Showcases Promise of Telomir-1

Updated Category News Views 113

Telomir Pharmaceuticals' Advancements in Drug Development Telomir Pharmaceuticals, Inc. has recently made headlines with the promising preclinical findings related to its innovative compound, Telomir-1. This compound has demonstrated strong potential for treating Wilson's disease, a serious condition caused by an accumulation of copper in the body due to ATP7B mutations,...

Continue Reading